BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11377864)

  • 1. Sulfa drug screening in yeast: fifteen sulfa drugs compete with p-aminobenzoate in Saccharomyces cerevisiae.
    Castelli LA; Nguyen NP; Macreadie IG
    FEMS Microbiol Lett; 2001 May; 199(2):181-4. PubMed ID: 11377864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
    Iliades P; Berglez J; Meshnick S; Macreadie I
    Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfa drugs strike more than once.
    Patel OG; Mberu EK; Nzila AM; Macreadie IG
    Trends Parasitol; 2004 Jan; 20(1):1-3. PubMed ID: 14700578
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition studies of sulfonamide-containing folate analogs in yeast.
    Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
    Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae.
    Meneau I; Sanglard D; Bille J; Hauser PM
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2610-6. PubMed ID: 15215117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
    Patel O; Karnik K; Macreadie IG
    FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin B3 confers resistance to sulfa drugs in Saccharomyces cerevisiae.
    Kornfeld O; Nichols BP
    FEMS Microbiol Lett; 2005 Oct; 251(1):137-41. PubMed ID: 16112818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-aminobenzoate synthase gene of Saccharomyces cerevisiae encodes a bifunctional enzyme.
    Edman JC; Goldstein AL; Erbe JG
    Yeast; 1993 Jun; 9(6):669-75. PubMed ID: 8346682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid utilisation related to sulfa drug resistance in Saccharomyces cerevisiae.
    Bayly AM; Berglez JM; Patel O; Castelli LA; Hankins EG; Coloe P; Hopkins Sibley C; Macreadie IG
    FEMS Microbiol Lett; 2001 Nov; 204(2):387-90. PubMed ID: 11731153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
    Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
    Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae.
    Moukhlis R; Boyer J; Lacube P; Bolognini J; Roux P; Hennequin C
    Clin Microbiol Infect; 2010 May; 16(5):501-7. PubMed ID: 19673964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes.
    Peixoto MP; Beverley SM
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1575-8. PubMed ID: 3435106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. para-Aminobenzoic acid is a precursor in coenzyme Q6 biosynthesis in Saccharomyces cerevisiae.
    Marbois B; Xie LX; Choi S; Hirano K; Hyman K; Clarke CF
    J Biol Chem; 2010 Sep; 285(36):27827-38. PubMed ID: 20592037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
    Stein CR; Poole C; Kazanjian P; Meshnick SR
    Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system.
    Iliades P; Meshnick SR; Macreadie IG
    Microb Drug Resist; 2005; 11(1):1-8. PubMed ID: 15770087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.
    Zhang Y; Meshnick SR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):267-71. PubMed ID: 2024960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of aromatics in Saccharomyces cerevisiae--a feasibility study.
    Krömer JO; Nunez-Bernal D; Averesch NJ; Hampe J; Varela J; Varela C
    J Biotechnol; 2013 Jan; 163(2):184-93. PubMed ID: 22579724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mafenide on dihydropteroate synthase.
    Eagon RG; McManus AT
    J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.